These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1450727)

  • 1. Trans-activation by hepatitis B virus X protein is mediated via a tumour promoter pathway.
    Kekulé AS; Lauer U; Weiss L; Hofschneider PH; Koshy R
    Arch Virol Suppl; 1992; 4():63-4. PubMed ID: 1450727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
    Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
    Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS; Lauer U; Weiss L; Luber B; Hofschneider PH
    Nature; 1993 Feb; 361(6414):742-5. PubMed ID: 8441471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
    Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level.
    Balsano C; Avantaggiati ML; Natoli G; De Marzio E; Will H; Perricaudet M; Levrero M
    Biochem Biophys Res Commun; 1991 May; 176(3):985-92. PubMed ID: 1645550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the hepatitis B virus genome in hepatocellular carcinoma using PCR and demonstration of a potential trans-activator encoded by the frequently detected fragment.
    Ramesh R; Panda SK; Jameel S; Rajasambandam P
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():327-34. PubMed ID: 8113754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
    Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
    Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP1 site of E element in the enhancer I (EnI) in human liver cell.
    Lee DH; Choi BH; Rho HM
    Biochem Biophys Res Commun; 1999 Nov; 265(1):62-6. PubMed ID: 10548491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings.
    Kang-Park S; Lee JH; Shin JH; Lee YI
    Biochem Biophys Res Commun; 2001 May; 283(2):303-7. PubMed ID: 11327698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-activation of HLA-DR gene by hepatitis B virus X gene product.
    Hu KQ; Vierling JM; Siddiqui A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7140-4. PubMed ID: 2169620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways.
    Murakami S; Cheong J; Ohno S; Matsushima K; Kaneko S
    Virology; 1994 Feb; 199(1):243-6. PubMed ID: 8116251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression.
    Cheng XK; Yu GZ; Li XD; Ren XQ
    Oncotarget; 2017 Jan; 8(1):1132-1140. PubMed ID: 27902472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors.
    Avantaggiati ML; Balsano C; Natoli G; De Marzio E; Will H; Elfassi E; Levrero M
    Arch Virol Suppl; 1992; 4():57-61. PubMed ID: 1450726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. trans-activation by the hepatitis B virus X protein shows cell-type specificity.
    Seto E; Zhou DX; Peterlin BM; Yen TS
    Virology; 1989 Dec; 173(2):764-6. PubMed ID: 2596037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.
    Hildt E; Hofschneider PH
    Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
    Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.
    Cross JC; Wen P; Rutter WJ
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8078-82. PubMed ID: 8367466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using proteomics to identify the HBx interactome in hepatitis B virus: how can this inform the clinic?
    Xie N; Chen X; Zhang T; Liu B; Huang C
    Expert Rev Proteomics; 2014 Feb; 11(1):59-74. PubMed ID: 24308553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.
    Iavarone M; Trabut JB; Delpuech O; Carnot F; Colombo M; Kremsdorf D; Bréchot C; Thiers V
    J Hepatol; 2003 Aug; 39(2):253-61. PubMed ID: 12873823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.